Combination treatments for schizophrenia.

Alexander L Miller

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Combination treatments, especially combinations of antipsychotics, are used frequently for schizophrenia, despite a paucity of evidence regarding their safety and efficacy. Because the literature basis is weak and expert recommendations are largely lacking, providers should be vigilant in documenting improved outcomes for patients thought to benefit from combination treatments. Target symptoms that have been studied include psychosis, cognitive deficits, and negative symptoms. The strongest evidence is for augmentation of clozapine with another antipsychotic or with electroconvulsive therapy for persistent positive symptoms. Combination treatments for cognitive deficits and negative symptoms are being actively investigated, but current evidence is insufficient to recommend available agents for these components of schizophrenia. It is important that appropriate monotherapies be given adequate trials before resorting to combination therapies.

Original languageEnglish (US)
Pages (from-to)19-23
Number of pages5
JournalCNS Spectrums
Volume9
Issue number9 Suppl 9
StatePublished - Sep 2004

Fingerprint

Schizophrenia
Antipsychotic Agents
Electroconvulsive Therapy
Clozapine
Therapeutics
Psychotic Disorders
Safety

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Cite this

Miller, A. L. (2004). Combination treatments for schizophrenia. CNS Spectrums, 9(9 Suppl 9), 19-23.

Combination treatments for schizophrenia. / Miller, Alexander L.

In: CNS Spectrums, Vol. 9, No. 9 Suppl 9, 09.2004, p. 19-23.

Research output: Contribution to journalArticle

Miller, AL 2004, 'Combination treatments for schizophrenia.', CNS Spectrums, vol. 9, no. 9 Suppl 9, pp. 19-23.
Miller AL. Combination treatments for schizophrenia. CNS Spectrums. 2004 Sep;9(9 Suppl 9):19-23.
Miller, Alexander L. / Combination treatments for schizophrenia. In: CNS Spectrums. 2004 ; Vol. 9, No. 9 Suppl 9. pp. 19-23.
@article{fa67d699c2464dd0b6d8ad7eb37d27f6,
title = "Combination treatments for schizophrenia.",
abstract = "Combination treatments, especially combinations of antipsychotics, are used frequently for schizophrenia, despite a paucity of evidence regarding their safety and efficacy. Because the literature basis is weak and expert recommendations are largely lacking, providers should be vigilant in documenting improved outcomes for patients thought to benefit from combination treatments. Target symptoms that have been studied include psychosis, cognitive deficits, and negative symptoms. The strongest evidence is for augmentation of clozapine with another antipsychotic or with electroconvulsive therapy for persistent positive symptoms. Combination treatments for cognitive deficits and negative symptoms are being actively investigated, but current evidence is insufficient to recommend available agents for these components of schizophrenia. It is important that appropriate monotherapies be given adequate trials before resorting to combination therapies.",
author = "Miller, {Alexander L}",
year = "2004",
month = "9",
language = "English (US)",
volume = "9",
pages = "19--23",
journal = "CNS Spectrums",
issn = "1092-8529",
publisher = "MBL Communications",
number = "9 Suppl 9",

}

TY - JOUR

T1 - Combination treatments for schizophrenia.

AU - Miller, Alexander L

PY - 2004/9

Y1 - 2004/9

N2 - Combination treatments, especially combinations of antipsychotics, are used frequently for schizophrenia, despite a paucity of evidence regarding their safety and efficacy. Because the literature basis is weak and expert recommendations are largely lacking, providers should be vigilant in documenting improved outcomes for patients thought to benefit from combination treatments. Target symptoms that have been studied include psychosis, cognitive deficits, and negative symptoms. The strongest evidence is for augmentation of clozapine with another antipsychotic or with electroconvulsive therapy for persistent positive symptoms. Combination treatments for cognitive deficits and negative symptoms are being actively investigated, but current evidence is insufficient to recommend available agents for these components of schizophrenia. It is important that appropriate monotherapies be given adequate trials before resorting to combination therapies.

AB - Combination treatments, especially combinations of antipsychotics, are used frequently for schizophrenia, despite a paucity of evidence regarding their safety and efficacy. Because the literature basis is weak and expert recommendations are largely lacking, providers should be vigilant in documenting improved outcomes for patients thought to benefit from combination treatments. Target symptoms that have been studied include psychosis, cognitive deficits, and negative symptoms. The strongest evidence is for augmentation of clozapine with another antipsychotic or with electroconvulsive therapy for persistent positive symptoms. Combination treatments for cognitive deficits and negative symptoms are being actively investigated, but current evidence is insufficient to recommend available agents for these components of schizophrenia. It is important that appropriate monotherapies be given adequate trials before resorting to combination therapies.

UR - http://www.scopus.com/inward/record.url?scp=16544363795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544363795&partnerID=8YFLogxK

M3 - Article

C2 - 15361808

AN - SCOPUS:16544363795

VL - 9

SP - 19

EP - 23

JO - CNS Spectrums

JF - CNS Spectrums

SN - 1092-8529

IS - 9 Suppl 9

ER -